Xencor | XNCR - PE Price to Earnings


Xencor reported $29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Merck USD 8.84 0.26 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Xencor USD 29.92 3.22 Sep/2022